Meet us at ESMO: Image Analysis Group presents how to increase efficiency and to de-risk the clinical development process
Dr. Roettger will discuss the challenges biotech companies face in oncology trials and explore IAG’s novel strategies to include advanced imaging biomarkers in the clinical development process. Given the increasing need for collaboration in therapy development, Dr. Roettger will introduce IAG’s technology-enabled, risk-sharing and mitigation partnerships and targeted development strategies.
IAG partners with biotechnology and pharmaceutical companies and supports their clinical research programmes with its scientific, operational and technological expertise. IAG takes a holistic approach to biotech’s clinical development and brings together:
- An efficient purpose-built cloud based system with embedded quality controls for trial data management (DYNAMIKA)
- Patented methodologies for quantitative assessment of treatment efficacy and safety
- Expertise to ensure regulatory compliance, targeted drug development and scientific credibility of your data
- Ensures that its bio-pharmaceutical clients gain the most benefits of early objective decision making on their treatment efficacy from utilizing advanced imaging techniques in their trials
Discover our risk assessment and management strategies to overcome the challenges in your oncology trial by contacting IAG at firstname.lastname@example.org
The ESMO Congress is the most influential annual meeting for oncology professionals in Europe. The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back. This exciting partnership creates a unique cancer congress in Europe with huge scientific reach and the true potential to improve the lives of cancer patients. More information on the conference here.
About Image Analysis Group
IMAGE ANALYSIS GROUP is a global group of companies with expertise in clinical R&D, medical image analysis, clinical trial design, regulatory and financial strategy for biotechnology companies involved in clinical research of rheumatology, immuno-oncology, inflammatory and degenerative diseases.